Genetic Testing Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Genetic Testing Market: By Testing Type (Predictive & Presymptomatic Testing, Carrier Testing, Prenatal & Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing Others) Technology (Cytogenetic Testing, Biochemical Testing, Molecular Testing) Sample Type (Blood, Saliva, Hair Others) Indication (Cancer, Cardiovascular Diseases, Neurological Diseases, Hematological Diseases, Rare Diseases Others) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Genetic Testing Market size was valued at USD 13.6 billion in 2021. It is expected to reach USD 29.88 billion by 2028 recording a CAGR of 11.9% during 2022-2028. The DNA, a chemical databank that conveys commands for the body’s utilities, is examined during genetic testing. Changes or mutations in the genes that may cause illness or disease can be discovered by genetic testing. The rise in the incidence of genetic diseases and the growing demand for identifying genetic disorders are two major factors driving growth in the global genetic testing market. Chronic diseases are primarily caused by genetic abnormalities. Genetic testing makes available technology that aid in the early discovery of various genetic illnesses, as well as treatment and prevention. Genetic testing is widely utilised for a variety of applications. In 2015, there were around 15.1 million new cancer cases worldwide, with more than half of these instances coming from economically developing countries such as India, China, and others. Prenatal genetic testing is a procedure that aids in the detection of genetic diseases in the foetus. Mutations in a person’s genes or chromosomes are the most common cause of genetic disorders. Aneuploidy, trisomy, monosomy, and a variety of other hereditary illnesses are among the most common genetic abnormalities. Pharmacogenomics is the study of congenital changes in human genes that influence a person’s pharmacological response. Pharmacogenomics is a field that combines pharmaceutical and genetic sciences. As a result, it is the science of customising a medicine depending on a person’s genetic composition. A predisposition is an increase in the likelihood of a disease developing as a result of a person’s genetic composition. A genetic predisposition is caused by specific genetic abnormalities that are passed down from one parent to the next.

Genetic Testing Market

MARKET SUMMARY
-
11.9%
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR–11.9%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Genetic Testing Market

  • The report on global genetic testing market gives historical, current, and future market sizes (US$ Bn) on the basis of test type, technology, application, end user, and region.
  • The genetic testing market report gives comprehensive outlook on genetic testing across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
Key Players
  • Qiagen N.V.
  • PerkinElmer, Inc.
  • Applied Biosystems
  • Biocartis S.A.
  • Genentech, Inc.
Genetic Testing Market Growth

Technological advancements in the genetic testing enhances the revenue of genetic testing market over the forecast years. Advanced genetic testing technology enhances the precision of analysis of clinical biomarkers. Moreover, innovations in the genetic tests offer efficient and safer technique in the disease detection that may reduce the miscarriage during the early stage of pregnancy. Furthermore, surge in adoption of genetic testing among the population, favorable reimbursement policies, and presence of skilled professionals are bolster the genetic testing market over the forecast timeframe. Moreover, rise in adoption for the personalized medicine, increase in demand for early stage disease diagnosis, surge in adoption of genetic testing in developed and developing countries, and sophisticated healthcare infrastructure are the major factors that are driving the growth of the genetic testing market.


North-America Got Significant Share

Genetic Testing Market

North America accounted for larger revenue share in global market with significant CAGR. Increase in prevalence of genetic disorders such as cancer, diabetes, and other chronic diseases, rise in demand for personalized medicine, and grow in R&D for the development of advanced tests by the market players are propel the genetic testing market in the North America region. Europe market projected to grow at significant rate owing to increase in adoption of advanced genetic tests, rise in health awareness among the population, increase in the incidence of genetic disorders are expected to enhance the market.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Findings of the Report

  • Global genetic testing market expanding at significant CAGR over 2021 to 2027 owing to launch of newer tests into market.
  • Based on application, cancer segment accounted for larger market revenue share in 2020 and projected gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global genetic testing market
Genetic Testing Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The genetic testing market is projected to expand at a CAGR of 11.9% during the forecast period

  • 10X Genomics, Inc.
  • Quest Diagnostics Incorporated
  • QIAGEN N.V.
  • Myriad Genetics Inc.
  • Bio-Rad Laboratories Inc.
  • Hoffmann-La Roche Ltd
  • Eurofins Scientific
  • Blueprint Genetics
  • Illumina Inc.
  • BGI Genomics
  • PerkinElmer Inc.
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.

North America is the fastest-growing region for genetic testing market


Report

Table Of Content

1. Executive Summary
2. Global Genetic Testing Market Introduction
2.1. Global Genetic Testing Market – Taxonomy
2.2. Global Genetic Testing Market –Definitions
2.2.1. By Testing Type
2.2.2. By Technology
2.2.3. By Sample Type
2.2.4. By Indication
2.2.5. By Region
3. Global Genetic Testing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Genetic Testing Market Dynamic Factors – Impact Analysis
3.6. Global Genetic Testing Market – Competition Landscape
4. Global Genetic Testing Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Genetic Testing Market, By Testing Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Predictive & Presymptomatic Testing
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Carrier Testing
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Prenatal & Newborn Testing
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Diagnostic Testing
5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Pharmacogenomic Testing
5.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Others
5.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
6. Global Genetic Testing Market, By Technology, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. Cytogenetic Testing
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Biochemical Testing
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Molecular Testing
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Genetic Testing Market, By Sample Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Blood
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Saliva
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Hair
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Others
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. Global Genetic Testing Market, By Indication, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. Cancer
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Cardiovascular Diseases
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Neurological Diseases
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Hematological Diseases
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Rare Diseases
8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Others
8.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.6.3. Market Opportunity Analysis
9. Global Genetic Testing Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Genetic Testing Market – Opportunity Analysis Index, By Testing Type, Technology, Sample Type, Indication, and Region, 2022-2028
10. North America Genetic Testing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. Testing Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Predictive & Presymptomatic Testing
10.1.2. Carrier Testing
10.1.3. Prenatal & Newborn Testing
10.1.4. Diagnostic Testing
10.1.5. Pharmacogenomic Testing
10.1.6. Others
10.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Cytogenetic Testing
10.2.2. Biochemical Testing
10.2.3. Molecular Testing
10.3. Sample Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Blood
10.3.2. Saliva
10.3.3. Hair
10.3.4. Others
10.4. Indication Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Cancer
10.4.2. Cardiovascular Diseases
10.4.3. Neurological Diseases
10.4.4. Hematological Diseases
10.4.5. Rare Diseases
10.4.6. Others
10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Genetic Testing Market – Opportunity Analysis Index, By Testing Type, Technology, Sample Type, Indication, and Country, 2022-2028
10.7. North America Genetic Testing Market Dynamics – Trends
11. Europe Genetic Testing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. Testing Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Predictive & Presymptomatic Testing
11.1.2. Carrier Testing
11.1.3. Prenatal & Newborn Testing
11.1.4. Diagnostic Testing
11.1.5. Pharmacogenomic Testing
11.1.6. Others
11.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Cytogenetic Testing
11.2.2. Biochemical Testing
11.2.3. Molecular Testing
11.3. Sample Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Blood
11.3.2. Saliva
11.3.3. Hair
11.3.4. Others
11.4. Indication Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Cancer
11.4.2. Cardiovascular Diseases
11.4.3. Neurological Diseases
11.4.4. Hematological Diseases
11.4.5. Rare Diseases
11.4.6. Others
11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Rest of Europe
11.6. Europe Genetic Testing Market – Opportunity Analysis Index, By Testing Type, Technology, Sample Type, Indication, and Country, 2022-2028
11.7. Europe Genetic Testing Market Dynamics – Trends
12. Asia-Pacific Genetic Testing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. Testing Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Predictive & Presymptomatic Testing
12.1.2. Carrier Testing
12.1.3. Prenatal & Newborn Testing
12.1.4. Diagnostic Testing
12.1.5. Pharmacogenomic Testing
12.1.6. Others
12.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Cytogenetic Testing
12.2.2. Biochemical Testing
12.2.3. Molecular Testing
12.3. Sample Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Blood
12.3.2. Saliva
12.3.3. Hair
12.3.4. Others
12.4. Indication Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Cancer
12.4.2. Cardiovascular Diseases
12.4.3. Neurological Diseases
12.4.4. Hematological Diseases
12.4.5. Rare Diseases
12.4.6. Others
12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Genetic Testing Market – Opportunity Analysis Index, By Testing Type, Technology, Sample Type, Indication, and Country, 2022-2028
12.7. Asia-Pacific Genetic Testing Market Dynamics – Trends
13. Latin America Genetic Testing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. Testing Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Predictive & Presymptomatic Testing
13.1.2. Carrier Testing
13.1.3. Prenatal & Newborn Testing
13.1.4. Diagnostic Testing
13.1.5. Pharmacogenomic Testing
13.1.6. Others
13.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Cytogenetic Testing
13.2.2. Biochemical Testing
13.2.3. Molecular Testing
13.3. Sample Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Blood
13.3.2. Saliva
13.3.3. Hair
13.3.4. Others
13.4. Indication Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Cancer
13.4.2. Cardiovascular Diseases
13.4.3. Neurological Diseases
13.4.4. Hematological Diseases
13.4.5. Rare Diseases
13.4.6. Others
13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Genetic Testing Market – Opportunity Analysis Index, By Testing Type, Technology, Sample Type, Indication, and Country, 2022-2028
13.7. Latin America Genetic Testing Market Dynamics – Trends
14. Middle East and Africa Genetic Testing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
14.1. Testing Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Predictive & Presymptomatic Testing
14.1.2. Carrier Testing
14.1.3. Prenatal & Newborn Testing
14.1.4. Diagnostic Testing
14.1.5. Pharmacogenomic Testing
14.1.6. Others
14.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Cytogenetic Testing
14.2.2. Biochemical Testing
14.2.3. Molecular Testing
14.3. Sample Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Blood
14.3.2. Saliva
14.3.3. Hair
14.3.4. Others
14.4. Indication Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Cancer
14.4.2. Cardiovascular Diseases
14.4.3. Neurological Diseases
14.4.4. Hematological Diseases
14.4.5. Rare Diseases
14.4.6. Others
14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA Genetic Testing Market – Opportunity Analysis Index, By Testing Type, Technology, Sample Type, Indication, and Country, 2022-2028
14.7. MEA Genetic Testing Market Dynamics – Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. 10X Genomics, Inc.
15.2.2. Quest Diagnostics Incorporated
15.2.3. QIAGEN N.V.
15.2.4. Myriad Genetics Inc.
15.2.5. Bio-Rad Laboratories Inc.
15.2.6. F. Hoffmann-La Roche Ltd
15.2.7. Eurofins Scientific
15.2.8. Blueprint Genetics
15.2.9. Illumina Inc.
15.2.10. BGI Genomics
15.2.11. PerkinElmer Inc.
15.2.12. Abbott Laboratories
15.2.13. Thermo Fisher Scientific Inc.
16. Research Methodology
17. Key Assumptions and Acronyms

Report

Company Profile

  • Qiagen N.V.
  • PerkinElmer, Inc.
  • Applied Biosystems
  • Biocartis S.A.
  • Genentech, Inc.
  • Hoffmann La Roche Ltd.
  • Quest Diagnostics
  • Illumina, Inc.
  • Bayer Diagnostics
  • Konica Minolta, Inc.
  • Abbott Laboratories
  • Myriad Genetics

Description

Genetic Testing Market size was valued at USD 13.6 billion in 2021. It is expected to reach USD 29.88 billion by 2028 recording a CAGR of 11.9% during 2022-2028. The DNA, a chemical databank that conveys commands for the body’s utilities, is examined during genetic testing. Changes or mutations in the genes that may cause illness or disease can be discovered by genetic testing. The rise in the incidence of genetic diseases and the growing demand for identifying genetic disorders are two major factors driving growth in the global genetic testing market. Chronic diseases are primarily caused by genetic abnormalities. Genetic testing makes available technology that aid in the early discovery of various genetic illnesses, as well as treatment and prevention. Genetic testing is widely utilised for a variety of applications. In 2015, there were around 15.1 million new cancer cases worldwide, with more than half of these instances coming from economically developing countries such as India, China, and others. Prenatal genetic testing is a procedure that aids in the detection of genetic diseases in the foetus. Mutations in a person’s genes or chromosomes are the most common cause of genetic disorders. Aneuploidy, trisomy, monosomy, and a variety of other hereditary illnesses are among the most common genetic abnormalities. Pharmacogenomics is the study of congenital changes in human genes that influence a person’s pharmacological response. Pharmacogenomics is a field that combines pharmaceutical and genetic sciences. As a result, it is the science of customising a medicine depending on a person’s genetic composition. A predisposition is an increase in the likelihood of a disease developing as a result of a person’s genetic composition. A genetic predisposition is caused by specific genetic abnormalities that are passed down from one parent to the next.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX